๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Hemolytic Disease of Newborn

PASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS] NCT06923111n/a12 sites๐Ÿ“ Hamburg๐Ÿ“ Heidelberg๐Ÿ“ Basildon Nova Laboratories Limited ยท Tests: Xromi A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke NCT05953584Phase 29 sites๐Ÿ“ Raipur๐Ÿ“ Delhi๐Ÿ“ Gujarat Forma Therapeutics, Inc. ยท Tests: Etavopivat, Hydroxyurea Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (ฮฒ)-Thalassemia NCT04143724Phase 226 sites๐Ÿ“ Los Angeles๐Ÿ“ New York๐Ÿ“ Guangzhou Celgene ยท Tests: ACE-536 Investigation of the Genetics of Hematologic Diseases NCT02720679n/a1 site๐Ÿ“ Memphis St. Jude Children's Research Hospital Clinical Study of Super Transplantation in the Treatment of Severe ฮฒ-thalassemia NCT06734520NA2 sites๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Guangzhou Women and Children's Medical Center ยท Tests: super-transplantation in 3 severe ฮฒ -thalassemia pediatric patients. Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease NCT07274254Phase 312 sites๐Ÿ“ Bordeaux๐Ÿ“ Bordeaux๐Ÿ“ Lille Nantes University Hospital ยท Tests: Lidocain, Placebo, Standard of care Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in ฮ’-thalassaemia Patients. NCT06655662Phase 13 sites๐Ÿ“ Guangxi๐Ÿ“ Shenzhen๐Ÿ“ Shenzhen Shenzhen Hemogen ยท Tests: ฮฒ-globin restored autologous hematopoietic stem cells A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia NCT06609226Phase 3107 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Los Angeles Novo Nordisk A/S ยท Tests: Etavopivat A, Etavopivat B, Etavopivat C Serial Assessment of Fertility Experiences NCT07116772n/a3 sites๐Ÿ“ Santo Domingo๐Ÿ“ Kingston๐Ÿ“ Mwanza Children's Hospital Medical Center, Cincinnati Long-term Follow-up Study of BHC001 for TDT NCT06314529n/a2 sites๐Ÿ“ Nanning๐Ÿ“ Changsha Bioray Laboratories ยท Tests: Assessments Blood Sampling for Research Related to Sickle Cell Disease NCT00542230n/a1 site๐Ÿ“ Bethesda National Institute of Diabetes and Digestive and Kidney Disโ€ฆ Sickle-cell Disease Registry of the GPOH NCT03327428n/a1 site๐Ÿ“ Heidelberg University Hospital Heidelberg A Study of Immune Suppression Treatment for People With Sickle Cell Disease or ฮฒ-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT) NCT05736419Phase 26 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Fludarabine, Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil, Rabbit ATG Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of Newborn NCT04218318NA1 site๐Ÿ“ Madinah Ministry of Health, Saudi Arabia ยท Tests: phototherapy Study of the Role of Genetic Modifiers in Hemoglobinopathies NCT05799118n/a26 sites๐Ÿ“ Boston๐Ÿ“ Luanda๐Ÿ“ Buenos Aires Cyprus Institute of Neurology and Genetics ยท Tests: GWAS Efficacy and Safety of SIL-8301 for Control of Hemolysis in a Uniform Sickle Cell Disease Endotype NCT07282210Phase 24 sites๐Ÿ“ Toronto๐Ÿ“ Toronto๐Ÿ“ Montreal Biossil Inc. ยท Tests: Senicapoc, Placebo Efficacy of Liberal Versus Restricted IV Fluid Approach in the Management of Sickle Cell Vaso-Occlusive Crisis NCT07188766NA2 sites๐Ÿ“ Dammam๐Ÿ“ Riyadh Imam Abdulrahman Bin Faisal University ยท Tests: Sodium Chloride (NaCl) 0.9 %, Sodium Chloride (NaCl) 0.9 % Physiology and Pathologies Linked to Human Splenic Function : Direct and Ex-vivo Perfusion Explorations NCT06418256n/a5 sites๐Ÿ“ Clichy๐Ÿ“ Paris๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris ยท Tests: Spleen, blood and plasma collection Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC NCT04528355n/a1 site๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: data collection MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies NCT05735717Phase 21 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: Fludarabine, Busulfan, Melphalan, Rituximab, Levetiracetam Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders NCT06147414n/a1 site๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris ยท Tests: Blood sample A Long-term Follow-up Study in Participants Who Received CS-101 NCT06479616NA1 site๐Ÿ“ Shanghai Children's Hospital of Fudan University ยท Tests: CS-101 Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises NCT06184126NA1 site๐Ÿ“ Baltimore University of Maryland, Baltimore ยท Tests: Virtual Reality Headset and Hand-Held Controllers, Blindfolding and Noise Cancelling A Pilot Study on Neuroimaging in SCD: Part of The Boston Consortium to Cure Sickle Cell Disease NCT04166526n/a1 site๐Ÿ“ Boston Boston Children's Hospital ยท Tests: FDNIRS-DCS, MRI Modified Diagnosis and Treatment of Neonatal Hemolysis With ETCOc in sNH NCT06832800EARLY Phase 11 site๐Ÿ“ Hangzhou Women's Hospital School Of Medicine Zhejiang University ยท Tests: MDT, control (current management) Molecular and Cellular Basis of Severe Forms of Dengue in Sickle Cell Patients NCT07000747n/a1 site๐Ÿ“ Pointe-ร -Pitre Centre Hospitalier Universitaire de la Guadeloupe ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders NCT04398628n/a76 sites๐Ÿ“ Phoenix๐Ÿ“ Little Rock๐Ÿ“ Los Angeles American Thrombosis and Hemostasis Network Pharmacokinetics, Efficacy and Safety of Twice Daily Dosing Regimen of Hydroxycarbamide Dispersible Tablets in Children With Sickle Cell Disease NCT06578507Phase 27 sites๐Ÿ“ Crรฉteil๐Ÿ“ Jossigny๐Ÿ“ Le Kremlin-Bicรชtre Theravia ยท Tests: Hydroxycarbamid Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders NCT03128996Phase 1, Phase 24 sites๐Ÿ“ New Haven๐Ÿ“ Wilmington๐Ÿ“ Grand Rapids Washington University School of Medicine ยท Tests: RIC regimen, GVHD prophylaxis regimen Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease NCT02447874Phase 1, Phase 22 sites๐Ÿ“ Atlanta๐Ÿ“ Atlanta Emory University ยท Tests: Arginine, Arginine (Loading), Arginine (Continuous)
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy